Literature DB >> 3944696

Late resistance to corticosteroids in nephrotic syndrome.

R N Srivastava, R K Agarwal, A Moudgil, U N Bhuyan.   

Abstract

Corticosteroid resistance appeared late in the course of relapsing nephrotic syndrome in 12 patients who previously had steroid-sensitive relapses for 0.8 to 13 years. In 11 patients, renal histology performed earlier in the course of the disease showed minimal change in eight, mesangial proliferative glomerulonephritis (MesPGN) in two, and focal segmental glomerulosclerosis (FSGS) in one. Renal biopsy in another patient and a repeat procedure in four of eight patients who initially showed minimal change was done after they had developed steroid resistance, and showed FSGS. Cyclophosphamide was given to 11 patients after they became steroid resistant, and induced remission in eight that continued for 1 to 2 years in two patients. The other six had relapses that were steroid sensitive, but three of them (two with FSGS and one with MesPGN) later became resistant to steroids as well as to cyclophosphamide. Of six patients with FSGS, four with initial or subsequent resistance to cyclophosphamide eventually developed renal insufficiency. The other two have remained in remission for 12 to 16 years; one of these did not receive cyclophosphamide. Our observations suggest that patients with late steroid resistance comprise a heterogeneous group; those with FSGS and resistance to cyclophosphamide therapy may have a poor outcome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3944696     DOI: 10.1016/s0022-3476(86)80770-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Pulse methylprednisolone treatment of idiopathic steroid-resistant nephrotic syndrome.

Authors:  Arvind Bagga; R N Srivastava
Journal:  Pediatr Nephrol       Date:  2002-04       Impact factor: 3.714

2.  Focal glomerulosclerosis treated with heparin.

Authors:  D R Lines; M Coleman; A Gallus
Journal:  Arch Dis Child       Date:  1989-06       Impact factor: 3.791

3.  Late steroid resistance in childhood nephrotic syndrome: do we now know more than 40 years ago?

Authors:  Oleh M Akchurin; Frederick J Kaskel
Journal:  Pediatr Nephrol       Date:  2013-05-25       Impact factor: 3.714

4.  Clinical course and NPHS2 analysis in patients with late steroid-resistant nephrotic syndrome.

Authors:  Peter Schwaderer; Tanja Knüppel; Martin Konrad; Otto Mehls; Karl Schärer; Franz Schaefer; Stefanie Weber
Journal:  Pediatr Nephrol       Date:  2007-11-14       Impact factor: 3.714

5.  Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome.

Authors:  D P Jones; F B Stapleton; S Roy; R J Wyatt
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

Review 6.  Pediatric renal problems in India.

Authors:  R N Srivastava
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

7.  Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome.

Authors:  R Elhence; S Gulati; V Kher; A Gupta; R K Sharma
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

8.  Long-Term Outcome of Secondary Steroid-Resistant Nephrotic Syndrome in Chinese Children.

Authors:  Daojing Ying; Wangkai Liu; Lizhi Chen; Liping Rong; Zhilang Lin; Sijia Wen; Hongjie Zhuang; Jinhua Li; Xiaoyun Jiang
Journal:  Kidney Int Rep       Date:  2021-05-12

9.  Rates of idiopathic childhood nephrotic syndrome relapse are lower during the COVID-19 pandemic.

Authors:  Clarkson Crane; Christine Bakhoum; Elizabeth Ingulli
Journal:  Pediatr Nephrol       Date:  2022-02-24       Impact factor: 3.651

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.